Fmoc-Dab(Boc)-OH structure
|
Common Name | Fmoc-Dab(Boc)-OH | ||
|---|---|---|---|---|
| CAS Number | 125238-99-5 | Molecular Weight | 440.489 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 669.4±55.0 °C at 760 mmHg | |
| Molecular Formula | C24H28N2O6 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | 358.7±31.5 °C | |
| Name | Fmoc-(N-gamma-Boc)-L-alpha,gamma-diaminobutyric acid |
|---|---|
| Synonym | More Synonyms |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 669.4±55.0 °C at 760 mmHg |
| Molecular Formula | C24H28N2O6 |
| Molecular Weight | 440.489 |
| Flash Point | 358.7±31.5 °C |
| Exact Mass | 440.194733 |
| PSA | 113.96000 |
| LogP | 5.40 |
| Vapour Pressure | 0.0±2.1 mmHg at 25°C |
| Index of Refraction | 1.584 |
| Storage condition | 2~8°C |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Hazard Codes | Xi |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| HS Code | 2924299090 |
|
~72%
Fmoc-Dab(Boc)-OH CAS#:125238-99-5 |
| Literature: Sakura, Naoki; Itoh, Tatsuya; Uchida, Yoshiki; Ohki, Kazuhiro; Okimura, Keiko; Chiba, Kenzo; Sato, Yuki; Sawanishi, Hiroyuki Bulletin of the Chemical Society of Japan, 2004 , vol. 77, # 10 p. 1915 - 1924 |
|
~%
Fmoc-Dab(Boc)-OH CAS#:125238-99-5 |
| Literature: Bulletin of the Chemical Society of Japan, , vol. 77, # 10 p. 1915 - 1924 |
|
~%
Fmoc-Dab(Boc)-OH CAS#:125238-99-5 |
| Literature: Synthetic Communications, , vol. 36, # 19 p. 2901 - 2912 |
|
~%
Fmoc-Dab(Boc)-OH CAS#:125238-99-5 |
| Literature: Synthetic Communications, , vol. 36, # 19 p. 2901 - 2912 |
| Precursor 3 | |
|---|---|
| DownStream 0 | |
| HS Code | 2924299090 |
|---|---|
| Summary | 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
|
Structure-activity relationships in ultrashort cationic lipopeptides: the effects of amino acid ring constraint on antibacterial activity.
Amino Acids 46(11) , 2517-30, (2014) Taking a minimalistic approach in efforts to lower the cost for the development of new synthetic antimicrobial peptides, ultrashort cationic lipopeptides were designed to mimic the amphiphilic nature ... |
| Fmoc-Dab(Boc)-OH |
| MFCD00151941 |
| Butanoic acid, 4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, (2S)- |
| (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-((tert-butoxycarbonyl)amino)butanoic acid |
| Glutamic acid, 4-[[(1,1-dimethylethoxy)carbonyl]amino]-, 5-(9H-fluoren-9-ylmethyl) ester |
| (2S)-2-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-4-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)butanoic acid |
| 2-Amino-5-(9H-fluoren-9-ylmethoxy)-4-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)-5-oxopentanoic acid |
| (2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid |
| (S)-4-(Boc-amino)-2-(Fmoc-amino)butyric acid |
| Fmoc-Daba(Boc)-OH |